Key result
Absence of IFN-gamma, Fas, CXCR3, or iNOS inhibition fails to alter BDV-induced neurological disease.
Borna disease virus-induced neurological disease does not depend on a single dominant T cell-dependent effector molecule such as interferon-gamma, Fas, CXCR3, or inducible NO synthase.
BDV neuropathogenesis in rodents proceeds independently of these effectors; leaves open identification of dominant T-cell mechanisms.
Borna disease virus (BDV) can induce severe neurological disorder in Lewis rats and MRL mice. Antiviral CD8 T cells have been shown to be the mediators of disease in these animals. To define molecules involved in the disease process, we performed infection studies in MRL mice lacking either interferon-gamma, a functional Fas/FasL system, chemokine receptor CXCR3, or inducible NO synthase. We further used transgenic MRL mice expressing interferon-gamma-inducible, T cell-attracting chemokine CXCL10 in brain astrocytes. After intracerebral infection with BDV, wild-type and mutant mice developed CD8 T cell responses and neurological disease at similar frequency and with similar kinetics, suggesting that these factors are not required for initiation and maintenance of the immunopathological process. Similarly, the course of disease could not be altered by treating infected MRL mice or Lewis rats with the drug L-N(6)-(1-iminoethyl)-lysine (L-NIL) that specifically blocks the activity of the inducible NO synthase. We therefore have excluded a number of important factors that have been demonstrated to be crucial in the pathogenesis of a broad number of pathologic conditions. Thus, BDV-induced disease may not result from the action of a single dominant T cell-dependent effector molecule. Disease rather reflects a combined influence of several as yet undefined factors from CD8 T cells.
No takes yet. Share an insight, caveat, or question.
Hausmann et al. (2004) studied Borna disease virus (BDV) induced neurological disorder. Genetic deletion of interferon-gamma, Fas/FasL, CXCR3, or iNOS, or L-NIL treatment vs. Wild-type animals was evaluated on Development of CD8 T cell responses and neurological disease. Absence of interferon-gamma, Fas, CXCR3, or inducible NO synthase, or treatment with L-NIL, did not alter the frequency or kinetics of BDV-induced neurological disease in mice and rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: